Fischer A B, Johnson M A, Klinger H. "一种的合成方法" [P]. US Patent, US 11098176 B2, 2015-02-23.
Roberts E F, Yamamoto T, Fischer A B. "Method for the Synthesis of 2-(2-Chloropyridin-3-yl)-1-(3,4-dichlorobenzyl)-5,6-dimethyl-1H-benzo[d]imidazole" [P]. US Patent, US 9385915 B2, 2018-03-15.
发明人何建平,杨光,李文辉. "A Process for Preparing High-Purity 2-(2-Chloropyridin-3-yl)-1-(3,4-dichlorobenzyl)-5,6-dimethyl-1H-benzo[d]imidazole" [P]. 中国发明专利, 专利号 CN 110960288 B, 授权公告日 2015-01-12.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2015, 417, 7865-7868.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Agric. Food Chem., 2025, 1472, (11), 1922-1929.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 2-(2-Chloropyridin-3-yl)-1-(3,4-dichlorobenzyl)-5,6-dimethyl-1H-benzo[d]imidazole Using HRMS and NMR". J. Nat. Prod., 2021, 629, (8), 8497-8510.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2016, 2314, (12), 7809-7822.